Cargando…

Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal Antibodies

Removal of the core fucose from the Fc region of humanized monoclonal antibodies (afucosylated antibodies) enhances their antibody-dependent cell cytotoxicity activities in killing cancer cells. Based on the authors’ experience and literature, administrations of afucosylated antibodies have been ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adedeji, Adeyemi O., Zhong, Fiona, Getz, Jennifer A., Zhong, Zoe, Halpern, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806483/ https://www.ncbi.nlm.nih.gov/pubmed/36329562 http://dx.doi.org/10.1177/01926233221131510

Ejemplares similares

Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration
por: Wang, Qin, et al.
Publicado: (2018)

Liquid chromatography-mass spectrometry method for the quantification of an anti-sclerostin monoclonal antibody in cynomolgus monkey serum
por: Gao, Yuxiong, et al.
Publicado: (2021)

Reduced Fasting Duration in Cynomolgus Monkeys Enhances Animal Welfare During Toxicology Studies
por: Adedeji, Adeyemi O., et al.
Publicado: (2023)

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
por: Caracciolo, Daniele, et al.
Publicado: (2021)

The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity
por: Pereira, Natasha A., et al.
Publicado: (2018)

Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging
por: Kamath, Amrita V., et al.
Publicado: (2012)

Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys
por: Vugmeyster, Yulia, et al.
Publicado: (2010)

Modeling the pharmacokinetic‐pharmacodynamic relationship of the monoclonal anti‐macaque‐IL‐15 antibody Hu714MuXHu in cynomolgus monkeys
por: Pan, Wei. J., et al.
Publicado: (2016)

Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
por: Walter, Sarah, et al.
Publicado: (2014)

Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis
por: Choi, Eun Wha, et al.
Publicado: (2018)

In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
por: Aweda, Tolulope A., et al.
Publicado: (2022)

Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys
por: Loberg, Lise I., et al.
Publicado: (2021)

Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
por: Huang, Sijia, et al.
Publicado: (2018)

Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcγRIIIA binding affinity
por: Hatfield, Grayson, et al.
Publicado: (2022)

Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
por: Valente, Delphine, et al.
Publicado: (2020)

Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimization
por: Bheemareddy, Bala Reddy, et al.
Publicado: (2022)

Thirteen-week Intravenous Toxicity Study of a Novel Humanized Anti-Human Death Receptor 5 Monoclonal Antibody, CS-1008, in Cynomolgus Monkeys
por: Kimotsuki, Tomofumi, et al.
Publicado: (2010)

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis)
por: Ukaji, Takao, et al.
Publicado: (2018)

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys
por: In, Hyun Ju, et al.
Publicado: (2018)

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
por: Chakraborty, Saborni, et al.
Publicado: (2022)

Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregates
por: Kwiatkowski, Allyson, et al.
Publicado: (2020)

Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
por: Shatz, Whitney, et al.
Publicado: (2013)

Assessing in vivo dynamics of multiple quality attributes from a therapeutic IgG4 monoclonal antibody circulating in cynomolgus monkey
por: Li, Yinyin, et al.
Publicado: (2016)

Semi-mechanistic Multiple-Analyte Pharmacokinetic Model for an Antibody-Drug-Conjugate in Cynomolgus Monkeys
por: Lu, Dan, et al.
Publicado: (2014)

Generation of FX (−/−) and Gmds (−/−) CHOZN host cell lines for the production of afucosylated therapeutic antibodies
por: Liu, Weiyi, et al.
Publicado: (2020)

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
por: Teo, Andrew, et al.
Publicado: (2023)

Anti-repulsive Guidance Molecule C (RGMc) Antibodies Increases Serum Iron in Rats and Cynomolgus Monkeys by Hepcidin Downregulation
por: Böser, Preethne, et al.
Publicado: (2015)

Keratoconus in a Cynomolgus Monkey
por: Kodama, Rinya, et al.
Publicado: (2010)

Erythrocytes of the Rhesus and Cynomolgus Monkeys
por: Stingo, Vincenzo
Publicado: (2019)

Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey
por: Zuch de Zafra, Christina L, et al.
Publicado: (2016)

Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
por: Jia, Jilei, et al.
Publicado: (2022)

Correction: Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
por: Teo, Andrew, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of ASKP1240, a Fully Human Anti-CD40 Antibody, in Normal and Renal Transplanted Cynomolgus Monkeys
por: Ma, Anlun, et al.
Publicado: (2014)

HTLV-1 Proliferation after CD8(+) Cell Depletion by Monoclonal Anti-CD8 Antibody Administration in Latently HTLV-1-Infected Cynomolgus Macaques
por: Nakamura-Hoshi, Midori, et al.
Publicado: (2023)

Sedative and physiological effects of alfaxalone intramuscular administration in cynomolgus monkeys (Macaca fascicularis)
por: WADA, Sou, et al.
Publicado: (2020)

Enzyme-linked immunosorbent assays for quantification of MMAE-conjugated ADCs and total antibodies in cynomolgus monkey sera
por: Pei, Min, et al.
Publicado: (2022)

Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation
por: Bharadwaj, Pranay, et al.
Publicado: (2022)

Bilateral Cataract in a Cynomolgus Monkey
por: Sasaki, Yuji, et al.
Publicado: (2011)

Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys
por: Desallais, Lucille, et al.
Publicado: (2016)

Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin
por: Li, Dongwei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_73pe11e2s9295e8g2diiem4317